Bilich, Tatjana <br/><br/>
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy.  [electronic resource] 

 -  Blood  02 2019 
 - 550-565 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2018-07-866830  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Neoplasm--immunology<br/>CD4-Positive T-Lymphocytes--immunology<br/>Epitopes, T-Lymphocyte--immunology<br/>Fusion Proteins, bcr-abl--immunology<br/>HLA Antigens--immunology<br/>Humans<br/>Immunotherapy<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--immunology<br/>Ligands<br/>T-Lymphocytes, Cytotoxic--immunology